Appearance of a novel prostacyclin receptor antibody and duration of spinal cord inquiry

Journal of Spinal Cord Medicine

Volumn 28, Issue 2, 2005, Pages 97-102

  Kahn, Nighat N ^a   Bauman, William A ^b   Sinha, Asru K ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Antibody; Cardiovascular disease; Platelets; Prostacyclin receptor; Spinal cord injuries

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PROSTACYCLIN RECEPTOR; PROSTACYCLIN RECEPTOR ANTIBODY; PROSTAGLANDIN E1; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CELL SURFACE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG RECEPTOR BINDING; HUMAN; MOLECULAR WEIGHT; OPTICAL DENSITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RECEPTOR AFFINITY; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE; THROMBOCYTE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FOLLOW UP; MIDDLE AGED; PARAPLEGIA; PATHOPHYSIOLOGY; QUADRIPLEGIA; TIME;

ADULT; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PARAPLEGIA; QUADRIPLEGIA; RECEPTORS, EPOPROSTENOL; SPINAL CORD INJURIES; TIME FACTORS;

EID: 20844449549     PISSN: 10790268     EISSN: None     Source Type: Journal    
DOI: 10.1080/10790268.2005.11753805     Document Type: Article

References (26)

1. Bauman WA, Kahn NN, Grimm DR, Spungen AM. Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury. Spinal Cord. 1999;37:601-616.
2. Phillips WT, Kiratli BJ, Sarkarati M, et al. Effect of spinal cord injury on the heart and cardiovascular fitness. Curr Probl Cardiol. 1998;23:641-716.
3. Bauman WA, Raza MA, Spungen AM, et al. Tomographic thallium myocardial perfusion imaging after intravenous dipyridamole in asymptomatic subjects with quadriplegia. Arch Phys Med Rehabil. 1993;174:740-744.
4. Kahn NN, Sinha AK, Bauman WA. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury. Clin Physiol. 2001;21:60-66.
5. Rossi EC, Green D, Rosen JS, et al. Sequential changes in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury. Br J Haematol. 1980;45:143-151.
6. Perkash A, Perkash V, Perkash I. Experiences with management of thromboembolism in patients with spinal cord injury: part 1. Incidence, diagnosis and role of risk factors. Paraplegia. 1979;16:322-331.
7. Lamb GC, Tomski MA, Kaufman J, et al. Is chronic spinal cord injury associated with increased risk of venous thromboembolism? J Am Paraplegia Soc. 1993;16:153-156
8. 2+channel blockers. Am J Physiol. 1999;276(39):E856-862.
9. Cimminiello CG, Arpaia M, Aloisio M, et al. Platelet-derived growth factor (PDGF) in patients with different degrees of chronic arterial obstructive disease. Angiology. 1994;45:289-293.
10. Badimon L, Cheseboro JH, Badimon JJ. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation. 1992;86(Suppl 6)111:74-85.
11. Colman RW, Marder VJ, Salzman EW, et al. Overview of hemostasis and thrombosis. In: Colman RW, Hirch J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Philadelphia, PA: Lippincott; 1987;3-17.
12. 1 binding to human platelet membrane by insulin and the activation of adenylate cyclase. J Biol Chem. 1990;265:4976-4981.
13. 2 receptor activity of platelets in acute ischemic heart disease. Circ Res. 1991;68:245-254.
14. Gieger J, Noltec C, Walter U. Regulation of calcium mobilization and entry in human platelets by endothelial-derived factors. Am J Physiol. 1994;267(Cell Physiol. 36):C236-244.
15. Kahn NN, Bauman WA, Sinha AK. Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans. Am J Physiol. 1993;34:H2160.
16. Kahn NN, Bauman WA, Sinha AK. Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin-induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury. Proc Natl Acad Sci U S A. 1996;93:245-249.
17. 3H-prostacyclin on platelets, J Clin Invest. 1979;63:215-220.
18. Kahn NN, Bauman WA, Sinha AK. Demonstration of a novel circulating anti-prostacyclin receptor antibody. Proc Natl Acad Sci U S A. 1997;94:8779-8782.
19. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acd Sci. 1949;51:666-672.
20. 2 receptor of human blood platelets, J Biol Chem. 1987;262(26):12685-12691.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 1970;227:680-685.
22. Demirel S, Demirel G, Tukek T, et al. Risk factors for coronary heart disease in patients with spinal cord injury in Turkey. Spinal Cord. 2001;39(3):134-138.
23. Mueller CA, Schuesener HJ, Conrad S, et al. Spinal cord injury induces lesional expression of the proinflammatory and antiangiogenic cytokine EMAP II. J Neurotrauma. 2003;20(10):1007-1015.
24. Hayes KC, Hull TC, Delaney GA, et al. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with spinal cord injury. J Neurotrauma. 2002;19(6):753-761.
25. Resetkova E, Morita T, Akasu F, Carayon P, Volpe R. In vitro effects of cytokines and human thyroglobulin on the induction of antibody-secreting cells in patients with auto-immune thyroid disease. Clin Invest Med. 1993;16(4):256-264.
26. Dong G, Ye R, Shi W, et al. IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients. Chin Med J (Engl). 2003;116(4):543-551.